Provided by Tiger Fintech (Singapore) Pte. Ltd.

PharmaCyte Biotech, Inc.

1.22
+0.01000.83%
Post-market: 1.220.00000.00%16:00 EDT
Volume:5.04K
Turnover:6.14K
Market Cap:8.41M
PE:0.94
High:1.24
Open:1.17
Low:1.17
Close:1.21
Loading ...
Sep 18, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 05, 2023

Correspondence

Form CORRESP - Correspondence
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2023

Major Issues Report

Form 8-K - Current report
Jun 17, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2023

Correspondence

Form CORRESP - Correspondence
May 30, 2023

Correspondence

Form CORRESP - Correspondence
May 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 12, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 11, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report